Patent details

EP3713919 Title: CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL) PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3713919
WO Application Number:
US2018062197
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP18821779.8
WO Publication Number:
WO2019104134
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
21/11/2018
Grant date:
02/08/2023
EP Publication Date:
30/09/2020
WO Publication Date:
31/05/2019
Claims Translations Received Date:
Claims Translation B1 Received Date:
10/08/2023
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
02/08/2023
EP B1 Publication Date:
02/08/2023
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
20/11/2038
Lapsed By Expiration Date:
Patent Validated Date:
26/08/2023
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
02/08/2023
 
 

 

Name:
Agios Pharmaceuticals, Inc.
Address:
88 Sidney Street, Cambridge, Massachusetts 02139, United States of America (US)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
25/08/2023
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
SIZEMORE, Jacob, P.
Address:
Shrewsbury MA 01545, United States of America (US)

2

Name:
GUO, Liting
Address:
Suzhou 215000, China (CN)

3

Name:
MIRMEHRABI, Mahmoud
Address:
Halifax Nova Scotia B3M 4T1, Canada (CA)

4

Name:
SU, Yeqing
Address:
Halifax Nova Scotia B3L 4R1, Canada (CA)

Priority

1

Priority Patent Number:
201862691709 P
Priority Date:
29/06/2018
Priority Country:
United States of America (US)

2

Priority Patent Number:
201762589822 P
Priority Date:
22/11/2017
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C07D 215/36; A61P 7/06; A61K 31/4709;

Publication

Bulletin

1

Bulletin Heading:
VB1
Journal edition number:
23/24
Publication date:
05/06/2024
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

2

Bulletin Heading:
EP3
Journal edition number:
35/23
Publication date:
30/08/2023
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
31/23
Publication date:
02/08/2023
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202423
Publication date:
05/06/2024
Description:
Opposition procedure started

2

Issue number:
202334
Publication date:
23/08/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202331
Publication date:
02/08/2023
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
30/11/2025
Annual Fee Number:
8
Annual Fee Amount:
280 Euro
Last Annual Payment Date:
26/11/2024
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
220 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date Document type Document Description Number of pages File Type
25/08/2023 Outgoing Correspondence Letter no formal defects 1 PDF /0/4/1/4/0/0800904140/docs/ep18821779.8_1_563259l271.pdf
10/08/2023 Claims First filed claims 2 PDF /0/4/1/4/0/0800904140/docs/ep18821779.8_0_claims20230810084501722.pdf